These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 19002747

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
    Hill AW, Guralnick RP, Wilson MJ, Habib F, Janies D.
    Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
    [Abstract] [Full Text] [Related]

  • 23. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T, Frecer V, De-Eknamkul W, Hannongbua S, Miertus S.
    Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T, Rungrotmongkol T, Bren U, Frecer V, Stanislav M.
    J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
    [Abstract] [Full Text] [Related]

  • 26. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W.
    J Med Chem; 2014 Oct 23; 57(20):8445-58. PubMed ID: 25255388
    [Abstract] [Full Text] [Related]

  • 27. Selective binding of antiinfluenza drugs and their analogues to 'open' and 'closed' conformations of H5N1 neuraminidase.
    Wang P, Zhang JZ.
    J Phys Chem B; 2010 Oct 14; 114(40):12958-64. PubMed ID: 20860351
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY, Boivin G, Roberts N.
    Antivir Ther; 2007 Oct 14; 12(4 Pt B):603-16. PubMed ID: 17944268
    [Abstract] [Full Text] [Related]

  • 31. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.
    Rameix-Welti MA, Agou F, Buchy P, Mardy S, Aubin JT, Véron M, van der Werf S, Naffakh N.
    Antimicrob Agents Chemother; 2006 Nov 14; 50(11):3809-15. PubMed ID: 16940075
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R, Kiso M, Igarashi M, Le QM, Sekijima M, Ito K, Takada A, Kawaoka Y.
    J Infect Dis; 2013 Jan 01; 207(1):89-97. PubMed ID: 23053629
    [Abstract] [Full Text] [Related]

  • 36. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
    Wei DQ, Du QS, Sun H, Chou KC.
    Biochem Biophys Res Commun; 2006 Jun 09; 344(3):1048-55. PubMed ID: 16647045
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Novel binding patterns between ganoderic acids and neuraminidase: Insights from docking, molecular dynamics and MM/PBSA studies.
    Yang Z, Wu F, Yuan X, Zhang L, Zhang S.
    J Mol Graph Model; 2016 Apr 09; 65():27-34. PubMed ID: 26905206
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.